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Abstract
Much experimental evidence suggests that an imbalance in cellular redox status is a major factor in the pathogenesis of Alzheimer’s disease
(AD). Our previous data showed a marked increase in membrane lipoperoxidation in primary fibroblasts from familial AD (FAD) patients. In
the present study, we demonstrate that when oligomeric structures of Ab 1-40 and Ab 1-42 are added to the culture media, they accumulate
quicker near the plasma membrane, and are internalized faster and mostly in APPV717I fibroblasts than in age-matched healthy cells; this
results in an earlier and sharper increase in the production of reactive oxygen species (ROS). Higher ROS production leads in turn to an
increase in membrane oxidative-injury and significant impairment of cellular antioxidant capacity, giving rise to apoptotic cascade activation
and finally to a necrotic outcome. In contrast, healthy fibroblasts appear more resistant to amyloid oxidative-attack, possibly as a result of their
plasma membrane integrity and powerful antioxidant capacity. Our data are consistent with increasing evidence that prefibrillar aggregates,
compared to mature fibrils, are likely the more toxic species of the peptides. These findings provide compelling evidence that cells bearing
increased membrane lipoperoxidation are more susceptible to aggregate toxicity as a result of their reduced ability to counteract amyloid
oligomeric attack.
© 2006 Elsevier Inc. All rights reserved.
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1. Introduction
A neuropathological characteristic of Alzheimer’s disease
(AD) is the extracellular accumulation of amyloid beta pep-
Abbreviations: Ab, amyloid b-peptide; ABTS, 2,2′-azino-di-3-
ethylbenzthiazoline sulphonate; AD, Alzheimer’s disease; APP, amyloid
precursor protein; CM-H2,DCFDA, 2′,7′-dichlorodihydrofluorescein diac-
etate; ECL, enhanced chemiluminescence; FAD, familial Alzheimer’s dis-
ease; GSH, glutathione; 4-HNE, 4-hydroxy-2-nonenal; MDA, malondialde-
hyde; PBS, phosphate buffer saline; PMSF, phenylmethylsulphonylfluoride;
PS, presenilin; ROS, reactive oxygen species; TAC, total antioxidant capac-
ity; ThT, thioflavine; TM-AFM, tapping mode atomic force microscopy
∗ Corresponding author. Tel.: +39 055 4598320; fax: +39 055 4598905.
E-mail address: cristina.cecchi@unifi.it (C. Cecchi).
tide (Ab) in neuritic plaques, whose appearance can precede
by decades the onset of symptoms [49]. Ab deposits in AD
patients are almost exclusively composed of the highly amy-
loidogenic 1-42 form (Ab 1-42), which is normally produced
by cells in much lower quantities than the 40 residues form
(Ab 1-40). Ab 1-42 is more prone to aggregation in vitro
thanAb 1-40, and its cytotoxicity is considered to be themain
cause of neuronal impairment in AD. In familial Alzheimer’s
disease (FAD) patients, an early increase has been reported in
the production of Ab 1-42 arising from intracellular process-
ing of amyloid precursor protein (APP) [63]. Interestingly,
all the observed mutations associated with FAD cases lead
independently to an increased production of Ab [18,58].
Autosomal dominant forms of FAD are often determined by
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specific mutations in the APP gene located on chromosome
21, or in the genes mapped on chromosomes 14 and 1, encod-
ing presenilin-1 (PS-1) and presenilin-2 (PS-2) respectively,
which are components of a large protein complex responsible
forg-secretase activity [20].AlthoughFAD is aminority (less
than 5%) of AD cases, these data point to a pathogenetic role
for the metabolism of APP and for the deposition of Ab. This
in turn suggests a role for Ab in the non-genetic AD forms,
since the pathological endpoint and hallmarks of familial and
sporadic AD are very similar.
Recent remarkable findings from research teams world-
wide, of protein aggregation as a common key feature in
several neurodegenerative diseases, constitute progress in
understanding the basicmechanismof the so-called “amyloid
hypothesis” of AD [29]. The amyloid hypothesis is supported
by in vivo and in vitro evidence concerning several amy-
loidogenic proteins that indicates a direct cytotoxic effect of
amyloid aggregates. Abundant data show that the prefibrillar
species of Ab peptides and of other amyloidogenic proteins
such as alpha-synuclein or transthyretin, which are formed
early in the process of fibrillogenesis, are neurotoxic,whereas
the mature fibrils are much less toxic [11,35,38,42,61,69].
It has recently been found that prefibrillar aggregates, but
not mature fibrils from proteins not involved in amyloid dis-
eases can impair cell viability when added to cultured cell
media [7,14]. It follows that the cross-b fold is not only the
structural feature common to all amyloid aggregates, but is
also the structural determinant of cytotoxicity of any amy-
loid aggregate. There is evidence that protein conversion into
toxic aggregates is enhanced by cellular membranes and that
self-assembly on the bilayer surface is critical for membrane
disruption [4]. A leading theory concerning the molecular
basis of amyloid toxicity is that a sub-population of prefibril-
lar aggregates, assembled in pore-like fashion, interacts with
cell membranes and provides them with non-specific pores
leading to free Ca2+ homeostasis imbalance [61,26,40]. The
rise in free calcium is usually coupled to a marked increase
in reactive oxygen species (ROS). This is a result of the
activation of oxidative metabolism following the increased
need for ATP required by the calcium pumps to clear the
excess free Ca2+ [53]. ROS increase may in turn reinforce
the increase in free Ca2+, of which extrusion from the cytosol
is inhibited by calcium pump oxidation. Other studies have
shown that the role ofmethionine 35 (Met-35), in conjunction
with the secondary structure of the Ab 1-42 itself, is critical
for the oxidative and neurotoxic properties of the peptide
[10]. Mutagenesis studies on the C-terminal helical region
of the peptide suggest that presence of Ab 1-42 in the lipid
bilayer is necessary for induction of Met-35 lipid peroxida-
tion and subsequent neurotoxicity. Several lines of evidence
support the possibility that interactions of Ab peptide causes
mitochondrial damage upon translocation of protofibrils to
the membranes [31]. Mitochondria are the major subcellular
source of superoxide anion radical, which can interact with
nitric oxide (NO) to form peroxynitrite [12,71]. ROS and
peroxynitrite accumulation results in damage tomajormacro-
molecules in cells, including lipids, proteins and nucleic acids
[47,60,62,68]. The lipoperoxidation process could influence
the pathogenesis of AD [55,59]. Indeed, 4-hydroxynonenal
(4-HNE), which is one of the most reactive end products
of lipoperoxidation, appears to induce neuronal death upon
binding to proteins by altering important transporter proteins,
such as the ATPases involved in calcium homeostasis and
the glutamate transporter EAAT2 [10,52]. The healthy brain
is protected from oxidative injury by antioxidant defences
that include antioxidant enzymes and free radical scavengers.
Many recent investigations have strengthened the hypothe-
sis that an impairment in cellular total antioxidant capacity
(TAC) plays a central role in AD [47,46]. Recently, we have
found that lymphoblasts and fibroblasts carrying APP and
PS-1 genemutations have a significant TAC impairment com-
pared to healthy controls [15].
The data reported in the last few years have considerably
improved our knowledge of the molecular basis of protein
aggregation into amyloid assemblies, and of the relation
between aggregate structure and toxicity to exposed cells
[23]. However, one of the intriguing issues that have not been
elucidated is the pathological role of each specific Ab aggre-
gates in AD brain areas. Studies on autopsied brain tissue
cannot reveal the early biochemical anomalies induced by
various forms of Ab aggregates, so we carried out a study
of cultured skin fibroblasts from FAD patients bearing either
APP or PS-1 gene mutations, and age-matched healthy con-
trol cells whose culture mediumwas supplemented by a fixed
amount of amyloid aggregates at differing degrees of mat-
uration. The goal of the present research is to compare the
molecular basis of cell damage induced byprefibrillar andfib-
rillar forms of Ab 1-40 and Ab 1-42 aggregates, by checking
oxidative stressmarkers and either apoptotic or necrotic path-
way activation in FAD fibroblasts in comparison to healthy
cells. This is a new approach to the identification of early
modifications in living cells having a genetic drawback in tis-
sues where AD lesions occur. Our results agree with previous
evidence fromneuronal cells under various experimental con-
ditions. In particular, we found that the cell lines investigated
have very different susceptibility to toxic amyloid aggregates,
and that the difference in cell viability is related to their ability
to: (i) affect the rate of accumulation of amyloid assemblies
into the plasma membrane; (ii) prevent oligomeric inclusion;
(iii) buffer ROS production.
2. Materials and methods
2.1. Materials
All reagents were of analytical grade or the high-
est purity available. Unless otherwise stated, chemicals
were purchased from Sigma–Aldrich (Milan, Italy). 2′,7′-
Dichlorodihydrofluorescein diacetate (CM-H2, DCFDA) and
wheat germ agglutinin-conjugated fluorescein were from
Molecular Probes (Eugene, OR). PVDF Immobilio-P Trans-
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fer Membrane was obtained from Millipore Corporation
(Bedford, MA); Hybond N+ nylon membrane (Amer-
sham, Life Science, England). The rabbit anti caspase-
3/CPP32 polyclonal antibody was from Biosource Inter-
national (Camarillo, CA); secondary antibodies were from
Santa Cruz Biotechnology (Santa Cruz, CA). Quantity
One program for the image analysis and densitometry was
from Biorad (Hercules, CA). Ab 1-40 and Ab 1-42 pep-
tides, as trifluoroacetate salts, were purchased from Bachem
(Bu¨bendorf, Switzerland). LyophilizedAb 1-40 andAb 1-42
peptides were stored as powder at −20 ◦C until reconstitu-
tion in phosphate-buffered saline (PBS) without calcium and
magnesium, pH 7.2 at a concentration of 230mM. Reconsti-
tuted peptides were stored as aliquots at −20 ◦C until used.
Ab 1-40 and Ab 1-42 prefibrillar aggregates were obtained
by diluting aliquots of 230mM stock solutions, thawed at
room temperature, in serum free Dulbecco Modified Eagle’s
Medium (DMEM) and bath sonicated for 5min to break up
any cluster formation before adding to fibroblasts. Otherwise,
Ab 1-40 fibrillar aggregates were prepared by incubating
aliquots of 230mM Ab 1-40 stock solutions in PBS with-
out calcium and magnesium, pH 7.2 at 37 ◦C for 48 h, before
addition to cultures.
2.2. ThT assay
Ab 1-40 and Ab 1-42 peptides were incubated at a con-
centration of 230mM in PBS, pH 7.2 at 37 ◦C. At regular
time-intervals 10ml aliquots of each sample were added to
490ml of a solution containing 25mM ThT, 25mM phos-
phate buffer, pH 6.0. The steady-state fluorescence values
of the resulting samples were measured at 25 ◦C using a
2mm× 10mmpath length quartz cuvette and aPerkin-Elmer
LS 55 spectrofluorimeter (Wellesley, MA) equipped with a
thermostated cell holder attached to a Haake F8 water bath
(Karlsruhe, Germany). The excitation and emission wave-
lengths were 440 and 485 nm, respectively. All measured
fluorescence values are given after subtracting the ThT flu-
orescence intensity measured in the absence of protein and
normalized so that the final fluorescence intensity at the end-
point of the kinetic trace was 100%.
2.3. Tapping mode atomic force microscopy (TM-AFM)
20ml aliquots of Ab 1-40 and Ab 1-42 peptides were
deposited on freshly cleaved mica substrates and dried under
mild vacuum. TM-AFM images were acquired in air using
a Dimension 3000 microscope (Digital Instruments, Veeco,
Santa Barbara, CA) equippedwith a ‘G’ scanning head (max-
imum scan size 100mm) and a Multimode scanning probe
microscope equipped with a “E” scanning head (maximum
scan size 10mm). Single beam uncoated silicon cantilevers
were used (type OMCL-AC, Olympus, Japan). The drive fre-
quency was around 300 kHz; the scan rate was between 0.3
and 0.8Hz.
2.4. Cell culture and exposure to Aβ aggregates
In the present study we investigated twelve fibroblast cell
lines. Fibroblasts were obtained from four patients belonging
to two Italian families bearing the APP Val717Ile muta-
tion (mean±S.D., age = 55.2± 4.5 years) and from four
patients belonging to two other Italian families bearing the
PS-1 Met146Leu and Leu392Val mutations (mean±S.D.,
age = 47.52± 9.9 years), respectively. The patient clinical
assessment was done according to published guidelines [64]
and the AD diagnosis fulfilled the Diagnostic and Statisti-
cal Manual of Mental Disorders criteria (DSM-IV) [1]. Four
age-matched healthy subjects (mean±S.D., age = 52.3± 8.2
years) were also analyzed. The local ethical committee
approved the protocol of the study and written consent was
obtained from all subjects or, where appropriate, their care-
givers. All control subjects were tested and none of them
carried APP or PS-1 mutations. These subjects were also
carefully assessed with a rigorous diagnostic evaluation in
order to exclude diagnosis of other neurological disorders.
Skin biopsies of 3mm punch were obtained from the volar
side of the upper arm of the FAD patients and controls. Two
explants were performed from each biopsy and plated in 25-
cm2 flasks. The cells were grown in DMEM, supplemented
with 10% foetal bovine serum, and harvested at confluence
in T-25 flasks, 7 days after previous subculture. All fibroblast
lines were subjected to an equal number of passages (ranging
from 10 to 15) and analyzed in three different experiments
before confluence. Cultured fibroblasts were exposed to dif-
fering concentrations of Ab 1-40 and Ab 1-42 prefibrillar
aggregates (PF) and of Ab 1-40 fibrillar aggregates (F), pre-
pared as above described.
2.5. Time-course of Aβ aggregate binding to cell surface
membrane
3.5× 103 well−1 healthy and FADfibroblastswere treated
for differing times (0, 10, 20, 30, 60min) with 1.0mM Ab
aggregates in a 96-well plate and then washed twice with
PBS. The residual aggregate-cell complex was stained with
100ml of 1.0mM Congo Red in PBS for 20min. The Congo
Red content was measured photometrically at 490 nm (free
Congo Red) and 550 nm (bound Congo Red) with an ELISA
plate reader. Under these conditions, the optical density at
550 nmof theAb aggregate-CongoRed complex is ameasure
of the amount of aggregates adsorbed to the cell membrane
[22]. Congo Red values are reported as percentage increases
versus respective untreated fibroblasts (assumed as 100%).
2.6. Internalization of amyloid aggregates
The cells were plated on glass coverslips and incubated
with the prefibrillar aggregates of Ab 1-40 and Ab 1-42
(PF). Then the cells were counterstained with fluorescein-
conjugated wheat germ agglutinin (50mg/ml) for 15min
to detect plasma membrane profiles and fixed in 2.0%
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buffered paraformaldehyde for 10min at room temperature.
Subsequently, permeabilization of plasma membranes was
achieved by cell treatment with 3.0% glycerol solution in
PBS with a 0.5% bovine serum albumin. In order to verify
aggregate internalization, a set of experimentswas carried out
in the same experimental conditions without glycerol solu-
tion in non-permeabilized cells. After washing, the coverslips
were incubated with mouse monoclonal anti-Ab antibodies
6E10 (Signet, DBA, Italy) diluted 1:1000 in PBS with 1%
foetal bovine serum for 60min. The immunoreaction was
revealed with Texas Red-conjugated anti-mouse secondary
antibodies (Vector Laboratories, DBA, Italy) diluted 1:1000
in PBS with 1% foetal bovine serum for 90min. Negative
controls were obtained by substituting blocking solution for
the primary antibody. The fluorescence was analyzed by
the confocal Bio-Rad MCR 1024 ES scanning microscope
(Hercules, CA) equipped with a krypton/argon laser source
(15mW) for fluorescence measurements using two emis-
sion lines at 568 and 488 nm for Texas Red and fluorescein
excitation, respectively. Observations were performed using
a Nikon Plan Apo 60× oil immersion objective. A series
of optical sections (512× 512 pixels) 1.0mm in thickness
was taken through the cells at intervals of 0.8mm. Quanti-
tation of surface bound aggregates and internalized aggre-
gates was achieved by public domain Java image processing
program (ImageJ). In particular, fluorescence is expressed
as fractional change above the resting baseline, 1F/F,
where F is the average baseline fluorescence before aggre-
gate exposure and 1F is the fluorescence change over the
baseline.
2.7. Measurement of intracellular ROS
Fibroblasts were cultured on glass coverslips and dye
loadingwas achievedby incubating the cellswith 5mMROS-
sensitive fluorescent probe (CM-H2, DCFDA) for 20min
at 37 ◦C in the culture medium. DCFH-DA fluorescence
into intact cells was detected using a confocal Bio-Rad
MCR 1024 ES scanning microscope. A series of optical
sections (512× 512 pixels) was taken through the depth
of the cells with a thickness of 1.0mm at intervals of
0.8mm. Twenty optical sections for each examined sam-
ple were then projected as a single composite image by
superimposition.
2.8. Purification of cytosolic fraction
Fibroblasts were washed twice in PBS and harvested
in 50mM Tris–HCl (pH 7.2), containing 0.1mM phenyl-
methylsulphonylfluoride (PMSF), 10mg/ml leupeptine and
10mg/ml aprotinin prior to storage at −80 ◦C until use.
Rupture of the plasma membrane was achieved by three
freeze–thaw cycles followed by centrifugation at 750× g for
10min at 4 ◦C. Cytosolic fractions were used for estima-
tion of total antioxidant capacity (TAC), lipoperoxidation,
DNA fragmentation and caspase-3/CPP32. Protein content
was measured in cytosolic fractions according to the method
of Bradford [5].
2.9. Oxidative markers
Total antioxidant capacity (TAC), accounting for total
hydrophilic scavengers, was assayed in cytosolic fractions of
cell lysates as reported aboveby a spectrophotometricmethod
(Total Antioxidant Status, Randox Laboratories LTD., Co.
Antrim, UK). Briefly, 2,2′-azino-di-[3-ethylbenzthiazoline
sulfonate] (ABTS) was incubated with a peroxidase (met-
myoglobin) and H2O2 to generate the blue-green radi-
cal cation ABTS•+ with maximum absorbance at 600 nm.
ABTS•+ is reduced in the presence of antioxidants pro-
portionally to the concentration of the latter. The results
are calibrated using a reference curve based on the soluble
antioxidant Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-
2-carboxylic acid) as a standard.
To assess the rate of lipid peroxidation, the levels of typ-
ical end products of the process: malondialdehyde (MDA)
and 4-hydroxyalkenals such as 4-hydroxynonenal (4-HNE)
were determined in the cytosolic fraction of cells lysated
as specified above. Measurements were made by using
a colorimetric method at 586 nm, according to the reac-
tion of the chromogen N-methyl-2-phenylindole, with MDA
and 4-HNE in the presence of methanesulfonic acid at
45 ◦C [24].
2.10. Amyloid cytotoxicity assay
The cytotoxicity of Ab aggregates was assessed using
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay. Fibroblasts were plated on 96-
well plates in 100ml of fresh medium. Before reaching
confluence, the cells were incubated with 100ml of fresh
media without serum in the presence of differing con-
centrations (0.001, 0.01, 0.1, 1.0, 10mM) of prefibrillar
and fibrillar Ab 1-40 aggregates or Ab 1-42 assemblies
for 24 h; in time course analysis, cells were exposed to
1mM amyloid aggregates for 48 and 72 h. The fibroblast
culture media were then transferred into a 96-well plates
to determine LDH release by using a colorimetric method
(Cytotoxicity Detection Kit LDH, Roche Diagnostics) and
were immediately replaced with 100ml of MTT solution
in PBS (0.5mg/ml final concentration). After fibroblast
incubation at 37 ◦C for 4 h, 100ml of cell lyses buffer (20%
SDS, 50% N,N-dimethylformamide, pH 4.7) was added
to each well and the samples were incubated overnight at
37 ◦C in a humidified incubator. Absorbance values of blue
formazan were determined at 590 nmwith an automatic plate
reader.
2.11. Apoptotic markers
DNA fragmentation, accounting for cell apoptosis, was
determined by using an immunometric method (Cell Death
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Detection ELISAPLUS, Roche Diagnostics) according to
the manufacturer’s instructions. DNA fragmentation was
expressed as the enrichment of histone-associated oligonu-
cleosomes released to the cytoplasm by measuring the
absorption at 405 nm.
Caspase-3 cleavage was measured after 15% SDS-PAGE
run of 20mg proteins. The gels were blotted on PVDF
Immobilon-P Transfer Membrane and probed by overnight
incubation with rabbit anti caspase-3/CPP32 polyclonal anti-
bodies. This was followed by incubation with the HRP-
conjugated secondary antibody and ECL. Band density of
the 17 kDa active fragment was measured as densitometric
units/mg protein using the image analysis and densitometry
program Quantity One.
2.12. Statistical analysis
All data are expressed as mean± standard deviation
(S.D.). Comparison between the different groups were per-
formed by ANOVA followed by Bonferroni t-test. A p-value
less than 0.05 was accepted as statistically significant.
3. Results
3.1. Aβ 1-40 and Aβ 1-42 aggregates
Ab 1-40 and Ab 1-42 peptides, as numerous proteins
involved in different pathological conditions, convert from
their soluble form into highly ordered aggregates referred
to as amyloid fibrils [38,61]. These aggregates are typically
characterized by a high content of b-structure in which the
b-strands are perpendicular to the axis of the fibril and form
long b-sheets running along the length of the fibril [23].
The protofibrillar aggregates found in the first stages of the
aggregation process bind Thioflavine (ThT), as revealed by
an increase in fluorescence intensity following addition of
small aliquots of the solution in which they are present.
Fig. 1. (A) Time-courses of Ab 1-40 (empty symbols, dashed line) and Ab 1-42 (filled symbols, solid line) aggregation measured by ThT fluorescence. The
peptides were incubated as described in Section 2. The continuous lines through the data represent the best fits to single exponential function. (B and D)
TM-AFM images of prefibrillar and fibrillar structures of Ab 1-40 taken in air without or with incubation at 37 ◦C for 48 h, respectively. (C) TM-AFM image
of Ab 1-42 globular aggregates taken in air after Ab 1-42 dilution. (B) Scan size 1.4mm, Z range 7.8 nm; (C) scan size 672 nm, Z range 4.7 nm; (D) scan size
5.0mm, Z range 25 nm. Scale bars represent B, 150 nm; C, 70 nm; D, 500 nm.
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Fig. 1A shows the time course of the change of ThT fluo-
rescence as the protein aggregates formed. Whereas the Ab
1-40 fibrillar aggregates (F) developed after a lag phase, the
Ab 1-42 assemblies reached the maximum ThT fluorescence
after few minutes. In addition, aliquots of solutions of Ab
1-40 and Ab 1-42 were analyzed using tapping mode atomic
force microscopy (TM-AFM) in order to investigate aggre-
gate morphology. As the sample was dried to facilitate its
adhesion to the mica substrate, the measured aggregate sizes
reported below are reduced with respect to fully hydrated
conditions. From previous experiments, the shrinking factor
turns out to be 2.0–2.5. In the early stages of the aggrega-
tion process, the Ab 1-40 and Ab 1-42 aggregates show the
morphology typical of protofibrillar structures (PF) (Fig. 1B
and C, respectively). Globular structures are observed in both
cases: within the experimental error, the globule heights are
compatible for Ab 1-40 and for Ab 1-42, being 0.5± 0.1
and 0.4± 0.1 nm, respectively. In our experimental condi-
tions, a small percentage (less than 8%) of the Ab 1-40
globules displays the tendency to self-assemble into beaded
chains composed of several units resembling typical amyloid
protofibrils (Fig. 1B). After 48 h of incubation, a significant
amount of fibrils (3.1± 0.1 nm high) coexisting with globu-
lar assemblies, larger (10–15 nm high) than those observed
at the early stages of the aggregation, were observed for Ab
1-40 (Fig. 1D).
3.2. Amyloid aggregates penetrate into fibroblasts
It is widely accepted that cell degeneration in amyloid
diseases is mediated by a toxic mechanism involving the
interaction of the aggregated species with the plasma mem-
brane of the affected cells [61].Wepreviously reported a clear
increase in membrane lipoperoxidation level in peripheral
cells from FAD patients compared to age-matched healthy
subjects [15]. Here, we investigate whether the oxidative-
damaged membranes of APPV717I fibroblasts enhance the
adsorption of the amyloid assemblies on the cellular sur-
faces. The time-course of aggregate binding to APPV717I
and to wild-type cells was performed by exposure for vary-
ing lengths of time to 1.0mMAb 1-40 orAb 1-42 aggregates;
finally the cells were washed with PBS and stained with
1.0mMCongo Red. It can be seen that, prefibrillar aggregate
binding to membranes was considerably earlier and higher
in APPV717I than in wild-type fibroblasts (Fig. 2A and C).
No significant difference in Congo Red absorbance values
between untreated wild-type and APPV717I fibroblasts was
observed. The aggregate binding capacity of cells was sat-
urable, reaching its limit in 60min. An equal cell number
from cultures with a comparable division rate from different
donors were exposed to the aggregates in order to exclude the
influence of these factors on the amount of Ab bounded to
the cell surface. The poor adsorption of Ab 1-40 mature fib-
rils to APPV717I fibroblasts was likely due to the presence,
in the samples, of minute amounts of residual prefibrillar
aggregates, although a specific, yet moderate, fibril binding
Fig. 2. Time-course of Ab binding to wild-type and APPV717I fibroblasts.
Both cell lines were exposed for 10, 20, 30, 60min to 1.0mM Ab aggre-
gates and then washed twice with PBS. The residual aggregate–cell complex
was stained with 1.0mM Congo Red for 20min. Under these conditions,
Congo Red-staining is a measure of the amount of prefibrillar aggregates
adsorbed to cell membrane surface. Wild-type and APPV717I fibroblasts
were treated with: (A) Ab 1-40 PF; (B) Ab 1-40 F; (C) Ab 1-42. All values
are expressed as means±S.D. of two independent experiments each carried
out in duplicate. No significant difference was observed in the absorbance
values measured in untreated fibroblasts (0.049± 0.005 in wild-type and
0.047± 0.004 in APPV717I). *Significant difference (p≤ 0.05) vs. wild-
type.
cannot be ruled out (Fig. 2B). This evidence is consistent
with confocal microscopic analysis at different focal lengths
of fibroblasts exposed for 20 and 60min to the amyloid
aggregates. The presence of amyloid aggregates penetrating
into the plasma membrane and cytoplasm of fibroblasts was
detected by immunofluorescence using monoclonal anti-Ab
antibodies after cell membrane permeabilization with glyc-
erol (Fig. 3A and C). The amyloid oligomers, added to the
fibroblast culture medium, accumulate more quickly near the
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Fig. 3. (A and C) Representative confocal microscopy images showing aggregates in contact with, and penetrating into, the plasma membrane and cytoplasm
of fibroblasts after treatment for 0, 20, 60min with Ab 1-40 and Ab 1-42 prefibrillar aggregates, respectively. Counterstaining was performed with fluorescein-
conjugated wheat germ agglutinin to detect plasma membrane profile (green). The aggregates were labeled with monoclonal mouse 6E10 anti-Ab antibodies
and Texas Red-conjugated anti-mouse secondary antibodies with or without plasma membrane permeabilization with glycerol as specified under Section
2. Images of a median optical section of 60min Ab-treated fibroblasts, non-permeabilized with glycerol, were shown as negative controls of intracellular
immunofluorescence signals. (B) Negative control. The cells were incubated with aggregates and then only with secondary antibody without primary antibody.
plasma membrane, and are internalised more rapidly and to a
greater extent in APPV717I mutated fibroblasts than in wild-
type ones. In contrast, in fibroblasts from healthy subjects
just few aggregates following longer time of protein exposure
can be observed. Furthermore, Ab 1-42 assemblies share a
more rapid kinetic of interaction with cell surfaces than Ab
1-40 aggregates in mutated fibroblasts. Images of a median
optical section of Ab-treated fibroblasts, non-permeabilized
with glycerol, confirmed that the intracellular immunofluo-
rescence signals, observed in permeabilized cells, are due
to internalized aggregates rather than to oligomers bound
to cellular surface. Negative controls obtained by incuba-
tion of fibroblasts with secondary antibody without primary
anti-Ab antibody verified the specificity of fluorescence sig-
nals (Fig. 3B). Cellular confocal analysis of the aggregates
directly labeled with Texas Red also confirmed the internal-
ization process into the fibroblasts (data not shown). Quan-
titation analysis of the amount of aggregates bounded to cell
membranes, after 20min of exposure, and inside the cells,
after 60min of exposure, supported our evidence on the
internalization process of Ab aggregates (Fig. 4). No signifi-
cant difference in the relative Texas Red fluorescence values
between untreated wild-type and APPV717I fibroblasts was
observed. To verify internalization data, a Z-series of 0.5mm
optical sections, from the basal to apical surface ofAPPV717I
fibroblasts, was performed by confocal microscopy analysis.
As shown in Fig. 5, Ab 1-42 prefibrillar aggregates were evi-
dently localizedwithin the cells just after 20min of treatment.
3.3. Oxidative stress
There is strong experimental evidence that oxidative stress
is an early biochemical modification in cells facing amyloid
aggregates [9,12,54,61]. It is well known that oxidative stress
can be caused by increased free radical production and/or
weakening of cellular antioxidant defences, which include
antioxidant enzymes, lipophilic and hydrophilic scavengers.
We have recently found that lymphoblasts and fibroblasts
from FAD patients with APPV717I and PS-1 gene mutations
had lower basal TAC than healthy controls [15,16]. In the
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Fig. 4. Time course of the aggregates bounded to surface (empty sym-
bols, dashed line) of wild-type fibroblasts (♦) and APPV717I fibroblasts
() or aggregate internalization within the cells (filled symbols, solid line).
Quantitation analysis of fluorescence signals are expressed as % changes
(means±S.D.) vs. respective untreated wild-type (30.2± 8.2 fluorescence
arbitrary units) and APPV717I (36.3± 7.1 fluorescence arbitrary units)
fibroblasts (assumed as 100%) of three independent experiments each carried
out in duplicate.
present study, we measured the change in non-enzymatic,
hydrophilic TAC, relating it to the effect of differing amyloid
species. In particular, TAC was affected more by prefibrillar
Ab 1-40 and Ab 1-42 aggregate treatment in fibroblasts car-
rying APPV717I mutation than in wild-type cells (Table 1).
PS-1 fibroblasts also fell slightly in antioxidant capacity fol-
lowing amyloid aggregate exposure. The reduced ability of
APPV717I cells to counteract Ab aggregate oxidative attack
was confirmed by the significant increase in intracellularROS
production in the first 20min of amyloid aggregate treat-
ment (Fig. 6A–C). Indeed, a time-course confocal analysis
of the ROS content showed an earlier and sharper increase in
APPV717I fibroblasts than in control cells following either
exposure to prefibrillar or fibrillar Ab 1-40 and Ab 1-42
aggregates. In particular, ROS increase induced by Ab 1-40
fibrillar aggregates appears as a result of the internalization
of some residual prefibrillar assemblies eventually present in
the aggregate solution. A later moderate increase was also
clear in control cells after 10min exposure to Ab 1-40 pre-
fibrillar structures, and after 20min exposure to Ab 1-42
aggregates. ROS accumulation resulted in a clear increase
in membrane lipoperoxidation, based on the levels of MDA
plus 4-HNE as stable and distinctive final lipoperoxidation
products (Table 1). In particular, Ab 1-42 aggregate exposure
Table 1
Alterations in antioxidant defences and lipoperoxidation levels induced by
amyloid aggregates in APPV717I, PS-1 and wild-type fibroblasts
TAC MDA and 4-HNE
Wild-type
Ab 1-40 PF 98± 14 115± 18
Ab 1-40 F 99± 13 106± 12
Ab 1-42 86± 16 133± 14
APPV717I
Ab 1-40 PF 65± 12* 144± 17*
Ab 1-40 F 84± 11 122± 10
Ab 1-42 48± 17* 175± 16*
PS-1
Ab 1-40 PF 89± 10 138± 13
Ab 1-40 F 92± 15 114± 17
Ab 1-42 81± 11 158± 20*
MDA, malondialdehyde; 4-HNE, 4-hydroxy-2-nonenal; TAC, total antiox-
idant capacity. Values are expressed as pecentage vs. untreated fibroblasts.
Data are means±S.D. of three independent experiments, each performed in
duplicate.
* p< 0.05 with respect to wild-type fibroblasts under the same aggregate
treatment.
induced stronger lipoperoxidation in APPV717I and PS-1
fibroblasts than in wild-type cells.
3.4. Amyloid cytotoxicity
Several recent studies suggest that prefibrillar aggregates
arising initially in the path of protein fibrillization are highly
cytotoxic, even when they are formed in vitro from peptides
not associated with protein deposition diseases [7,23,61].
We have previously reported that prefibrillar assemblies of
a protein domain, not associated with any disease, are more
cytotoxic than mature fibrils to a wide variety of cultured cell
lines [14]. In the present study, we first investigated whether
the toxicity of prefibrillar Ab 1-40 aggregates was compara-
ble in fibroblasts carrying APPV717I gene mutation and in
age-matched healthy control cells.All cell lineswere exposed
at 24, 48 and 72 h to 1.0mM prefibrillar Ab 1-40 aggre-
gates, and cell viability was then determined by the MTT
test. We found that cell viability was lessened in all cells
investigated, and that impairment was significantly greater
in APPV717I than in control fibroblasts (Fig. 7). In the more
susceptible APPV717I fibroblasts, the cytotoxicity depended
on the amount of aggregates added for 24 h to the culture
media, ranging from 6% at the lowest aggregate concentra-
tion (0.001mM) to 29% at the highest (10mM) (Fig. 8). In
contrast,MTT reduction altered less inAPPV717I fibroblasts
exposed to 0.001–10mM mature fibrils. However, the expo-
sure of APPV717I fibroblasts to differing concentrations of
Ab 1-42 aggregates triggered a deeper cytotoxic reaction to
Ab 1-40 prefibrillar and mature fibril Ab 1-40 assemblies
(Fig. 8). Correspondingly, release of cellular LDH into the
culture media of both wild-type and APPV717I fibroblasts
was greater upon 48 h exposure to 1mMAb 1-42 aggregates
than following exposure to prefibrillar and fibrillar Ab 1-40
species (Fig. 9). In any case, prefibrillar Ab 1-40 and Ab
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Fig. 5. Ab 1-42 prefibrillar aggregates are localized within the APPV717I fibroblasts after 20min treatment. A representative Z-series of 0.5mmoptical sections
was taken through cells by confocal microscopy. The aggregates were detected with monoclonal mouse 6E10 anti-Ab antibodies and Texas Red-conjugated
anti-mouse secondary antibodies as specified under Section 2.
1-42 aggregates induced a more significant LDH release in
APPV717I fibroblasts than in healthy controls.
3.5. Apoptotic markers
Abundant data indicates that toxicity of amyloid aggre-
gates stems from their ability to interact with cellmembranes,
triggering apoptotic and/or necrotic cell death [2,3,44,61].
Our previous report found a clear increase in free radical-
mediated injury toDNA in FADfibroblasts relative to healthy
controls [15]. In the present study, the observed enrich-
ment of histone-associated oligonucleosomes released to
the cytoplasm suggests a greater increase in DNA frag-
mentation in APPV717I and PS-1 fibroblasts exposed to
prefibrillar Ab 1-42 aggregates than in wild-type cells
(Table 2). Involvement of the apoptotic process was con-
firmed by the increased amount of the caspase-3/CPP32
active fragment (17 kDa) following amyloid exposure. In par-
ticular, caspase-3 was raised more in FAD than in wild-type
fibroblasts (Table 2).
Table 2
Apoptotic markers in APPV717I, PS-1 and wild-type fibroblasts following
amyloid aggregate exposure
DNA fragmentation Caspase-3 active fragment
Wild-type
Ab 1-40 PF 133± 17 119± 14
Ab 1-40 F 111± 23 101± 13
Ab 1-42 110± 8 111± 12
APPV717I
Ab 1-40 PF 160± 20 232± 18*
Ab 1-40 F 101± 13 137± 22*
Ab 1-42 155± 15* 182± 19*
PS-1
Ab 1-40 PF 167± 15* 133± 13
Ab 1-40 F 114± 10 97± 9
Ab 1-42 134± 19* 143± 14*
Values are expressed as percentage vs. untreated fibroblasts. Data are
means±S.D. of three independent experiments, each performed in dupli-
cate.
* p< 0.05 with respect to wild-type fibroblasts under the same aggregate
treatment.
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Fig. 6. (A and B) Continuous confocal microscopy analysis of intracel-
lular ROS production in unfixed APP and healthy fibroblasts during the
first 20min treatment with different amyloid aggregates. ROS levels were
imaged by confocal microscopy using the fluorescent dye CM-H2, DCFDA
as a probe according to the procedures described under Section 2. Fluores-
cence signals are expressed as fractional changes above the resting baseline,
1F/F, where F is the average baseline fluorescence before the application
of amyloid aggregates and 1F represents the fluorescence changes over
the baseline. Values are expressed as percentage vs. untreated fibroblasts.
The values shown are averages±S.D. of two independent experiments on
APPV717I and wild-type fibroblasts from four familial patients and from
four healthy subjects, respectively. *Significant difference (p≤ 0.05) vs.
wild-type.
4. Discussion
Several reports provide strong evidence for amyloid lipid
peroxidation within the AD brain [10,30,45,48,62,68]. Ab
can fragment and generate free radical peptides which have
potent lipoperoxidising effects on the synaptosomal mem-
branes in the neocortex [12,17,32]. However, studies of
autopsied brain tissue cannot clarifywhether abnormal oxida-
tive processes are inherent properties of AD cells or are
secondary to neurodegeneration. Since our previous results
showed a marked increase in oxidation levels of lipids and
proteins in peripheral cells from some FAD patients [15],
Fig. 7. Cell viability was checked by the MTT test in APPV717I fibroblasts
and wild-type fibroblasts exposed to 1.0mMAb 1-40 prefibrillar species vs.
cells not exposed to the aggregates. Values are expressed as % vs. untreated
fibroblasts. The reported values (means±S.D.) are representative of three
independent experiments, each performed in duplicate. *Significant differ-
ence (p≤ 0.05) vs. wild-type.
we investigated whether these early modifications could
influence the aggregation rate of amyloid assemblies and
the translocation process by which the amyloid assemblies
appear inside the fibroblasts. Under our experimental con-
ditions, Ab 1-40 and Ab 1-42 aggregates are characterized
by an extensive b-sheet structure able to bind ThT and are
endowed with typical morphological features of prefibril-
lar and fibrillar aggregates. We demonstrated that amyloid
oligomers, that were exogenously added to the fibroblast cul-
turemedium,were internalized faster andmore completely in
APPV717I than in wild-type fibroblasts, although the mech-
anism of aggregate translocation inside cells needs further
investigation. Our results suggest that the amyloid aggre-
gates can readily insert into oxidative-damaged fibroblasts
where the membrane integrity is compromised. Accordingly,
Fig. 8. The figure shows the percentage of viable APPV717I fibroblasts
exposed to varying amounts of prefibrillar (PF) or fibrillar (F) Ab 1-40
and Ab 1-42 aggregates respect to APPV717I untreated cells. The reported
values (means±S.D.) are expressed as percentage vs. untreated fibroblasts
and are representative of three independent experiments, each performed in
duplicate. *Significant difference (p≤ 0.05) vs. untreated cells.
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Fig. 9. The release of cellular LDH into the culture media of wild-type and
APPV717I fibroblasts without treatment or after 48 h exposure to 1mM of
prefibrillar (PF) or fibrillar (F)Ab1-40 andAb1-42 aggregates. The reported
values (means±S.D.) are expressed as percentage vs. untreated fibroblasts
and are representative of four independent experiments, each performed in
duplicate. *Significant difference (p≤ 0.05) vs. wild-type.
Ab is reported to accumulate faster in membranes contain-
ing oxidatively damaged phospholipids than in membranes
containing only unoxidized or saturated phospholipids [39].
Indeed, oxidatively damaged phospholipid membranes pro-
mote the transition of Ab to the b-sheet conformation, which
has a strong tendency to form fibrillar aggregates as dense
plaques in the brain. It is also possible that APPV717I fibrob-
lasts did not internalize amyloid aggregates unless cellular
blebbing was present. Our results, however, are consistent
with other previous studies showing intracellular accumu-
lation of Ab 1-40 and Ab 1-42 in granular deposits in
late endosomes and lysosomes of human fibroblasts, PC12,
monocytic and neuroblastoma cell lines [8,37,56,72]. It is
increasingly recognized that disruption of the integrity of cell
membranes by small prefibrillar assemblies probing into the
membrane bilayer is a primary step in the induction of oxida-
tive damage and after cell death [6,23,36,43,57,61]; the early
appearance of amyloid aggregates in the cytoplasm of fibrob-
lasts therefore suggests that these species are the main source
of oxidative stress for cells. Correspondingly, we found
prompt and sharp ROS production in APPV717I fibroblasts
exposed to Ab 1-40 and Ab 1-42 aggregates. Accordingly,
addition of Ab to PC12 cells induces increased ROS pro-
duction and apoptosis [12,27,50]. In contrast, treatment of
healthy control fibroblasts with small prefibrillar aggregates
induced a later and more moderate ROS increase. The sig-
nificant increase in intracellular ROS production could be
induced by a lesser ability of APPV717I cells to counteract
Ab aggregate oxidative attack. Our previous report demon-
strated significant impairment in TAC and GSH content in
peripheral cells from patients carrying APP or PS-1 muta-
tions, suggesting that a modified redox status is a common
feature of cells carrying these genetic lesions [15,16]. In the
present study, mutated fibroblasts exhibited larger decreases
in TAC following exposure to prefibrillar Ab 1-40 and Ab
1-42 aggregates than fibroblasts from healthy subjects. TAC
impairment could reflect chronic exposure to an oxidizing
environment in mutated fibroblasts with a continuous over-
production of amyloid peptide; it would therefore minimize
the protective effect against further oxidative injury following
amyloid peptide addition to cellular culture media. The TAC
decrease was greater in cells carrying APPV717I than the
PS-1 gene mutations. The moderate alteration in TAC in PS-
1 mutated fibroblasts strengthens the claim that the changes
observed are the direct outcome of the chronic presence of a
different grade of cellular oxidizing environment induced by
increasedAb production.Accordingly,we show that addition
of Ab aggregates to the fibroblast culture medium triggers
more extensive lipid peroxidation in cells carryingAPPV717I
or PS-1 gene mutations than in age-matched controls. This
effect was stronger in fibroblasts carrying APP rather than
PS-1 mutations. Our results therefore suggest that increase
in lipid peroxides is likely to result from attack on polyun-
saturated fatty acids in cell-membrane phospholipids by free
radicals. These findings on peripheral cells are in agreement
with several studies that provide evidence for excess lipoper-
oxidation and protein oxidation associated with Ab deposits
in APP and PS-1 AD brain and mutant mice [9,12,45,51,62].
It has been shown that 4-HNE, generated in response to
Ab-oxidative insults, can directly induce neuronal apopto-
sis at pathophysiological concentrations [41]. Another study
indicates, however, that although free radicals and lipid per-
oxidation may participate in the neurodegeneration process,
the mechanism of Ab-induced neurotoxicity does not appear
to involve ROS [73]. The present observations suggest that
prefibrillarAb1-40 aggregates aremore toxic than themature
fibrils, and have a dose-dependent effect. Our data are consis-
tent with increasing evidence that small soluble oligomers,
compared tomaturefibrils, are likely themore toxic species of
the peptides [10,11,19,35,38,42,69]. The moderate increase
in toxicity with the higher amount of Ab 1-40 mature fibrils
is likely to be the result of minute amounts of residual pre-
fibrillar aggregates in cell media, although a specific toxicity
of the fibrils cannot be ruled out. In particular, internalization
data of Ab 1-40 fibrils shown in Fig. 3B, the consequent ROS
production reported in Fig. 6B and the cytotoxic effect of Ab
1-40 fibrils shown in Fig. 8 and Table 2, concurrently suggest
that the more structured fibrils maintain some level of direct
toxicity. This encourages us to provide for further studies
aim to address the potential role of prefibrillar versus fibrillar
aggregates in mediating these effects. Some authors ques-
tion the use of the MTT assay as a reporter of Ab-mediated
cytotoxicity [70]. In contrast, according to other researchers,
the MTT assay, generally shows a good correlation with
other viability tests and in vivo results [21]. Therefore, even
though inhibition of MTT reduction represents a controver-
sial indicator of Ab-mediated cell injury, other corroborating
evidence was added in this study. Release of cellular LDH
into the culture media was specific to the prefibrillar form
of Ab 1-40, because the mature fibrils did not induce toxic-
ity at 48 h after treatment. In any case, prefibrillar Ab 1-40
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and Ab 1-42 aggregates induced a greater reduction in cell
viability and a larger increase in LDH release in APPV717I
fibroblasts than in healthy controls. Also, the exposure of
APPV717I fibroblasts to differing concentrations of Ab 1-
42 aggregates triggered a deeper cytotoxic reaction respect
to prefibrillar Ab 1-40 aggregates. The earlier accumulation
of Ab1-42 than Ab1-40 aggregates near the plasma mem-
brane, although similar amount of amyloid assemblies can
be internalized at longer time of exposure, can explain the
burst in ROS production with a stronger cell viability impair-
ment associated toAb1-42 treatment.Anyway, the increasing
evidence that Ab 1-42 is more hydrophobic, more prone to
aggregation, and more amyloidogenic than Ab 1-40 further
support the higher cytotoxic effect of Ab 1-42 peptide. It is
well known that the C-terminal hydrophobic tail is likely a
crucial feature of Ab 1-42 cytotoxicity, because of its role in
lipid bilayer inclusion [10]. A recent report speculates that
both Ab 1-40 and Ab 1-42 affect learning but only Ab 1-
42 causes extensive neurodegeneration in Drosophila brain
using the GAL4-UAS system [33]. Several studies suggest
that amyloid aggregate toxicity can trigger apoptotic and/or
necrotic cell death [2,3,16,44,61]. It is generally believed
that cell death associated with protein aggregates begins
with stimulation of the apoptotic response, although recent
data show necrotic rather than apoptotic death in some cases
[33,65,67,72]. Thebiochemistry of cell death following expo-
sure to the toxic amyloid aggregates is still under investiga-
tion, but our results support these suggestions. Indeed, despite
a marked increase in DNA fragmentation and in the caspase-
3 active fragment, necrosis appears to be the later outcome of
cell death, at least inAPPfibroblasts underAb1-42 aggregate
treatment. In addition, there was a greater increase in DNA
fragmentation in APP and PS-1 fibroblasts than in wild-type
cells following exposure to Ab 1-42 aggregates. Interest-
ingly, DNA fragmentation was positively correlated with cell
impairment or with ROS increase. Since the involvement of
caspases has been proposed in amyloid-induced apoptosis
in cultured neurons [28,34], we also investigated the acti-
vation of caspase-3/CPP32. The amount of caspase-3 active
fragment was clearly raised more in FAD than in wild-type
fibroblasts. In particular, the effect of prefibrillar Ab 1-40
and Ab 1-42 was more powerful than that of fibrillar Ab 1-
40 in both APP and PS-1 cells. The mechanism by which
caspase-3 is activated by differing amyloid treatment is yet
to be settled. Caspase activation may play a role that is not
necessarily related to apoptosis [13,25].
In conclusion, our data demonstrate an early internaliza-
tion of prefibrillar assemblies and a sharp increase in ROS
production induced inAPPV717Imutated fibroblasts follow-
ing exposure to prefibrillar amyloid aggregates. Impairment
of antioxidant capacity, lipid peroxidation, mitochondrial
dysfunction are all triggered, and apoptotic outcomes such
as DNA fragmentation, caspase-3 activation and finally LDH
release are induced; the latter is certain following exposure to
Ab 1-42 aggregates. Our results suggest that cells carrying an
altered proteolytic APP process, such as APPV717I fibrob-
lasts, have enhanced susceptibility to oxidative stress induced
by Ab exposure, which initially triggers the apoptotic path-
way and can ultimately lead to necrosis. This pattern relies on
a progressive amplification mechanism of the early reactive
free radicals by repeated chain reaction processes in mem-
brane lipids consistentwith the agedependenceofAD[66]. In
contrast, healthy control fibroblasts are more resistant to Ab-
oxidative attack, possibly because of their plasma membrane
integrity and powerful antioxidant capacity. This capacity is
clearly correlated with the viability of cells, explaining the
reduced necrotic outcome in healthy fibroblasts exposed to
the aggregates. These findings imply a systemic abnormal-
ity in FAD that could be important for the use of peripheral
cells in pre-clinical trials of antioxidant drugs. More data on
the biochemical modifications of increased susceptibility to
amyloid toxicity elicited by mutated cells is needed in order
to prevent such outcomes, and to design interventions that
aim to restore the resistance of cells affected by aggregates.
Acknowledgements
We thank Dr. Claudio Canale and Dr. Irene Forzoni for
technical advice. This study has been supported by grants
from the Italian MIUR (project numbers 2002058218 001
and 2005054147 001), from Min.Salute/ISS (no. 4AN/F12)
and from the Compagnia di San Paolo, Torino, Italy (ref. no.
2004.0995).
References
[1] American Psychiatric Association. Diagnostic and statistical manual
of mental disorders. 4th ed. Washington, DC: American Psychiatric
Association; 1994.
[2] Anderson AJ, Pike CJ, Cotman CW. Differential induction of
immediate early gene proteins in cultured neurons by b-amyloid
(Ab): association of c-Jun with Ab-induced apoptosis. J Neurochem
1995;65:1487–98.
[3] Behl C, Davis JB, Klier FG, Schubert D. Amyloid beta peptide induces
necrosis rather than apoptosis. Brain Res 1994;645:253–64.
[4] BokvistM, LindstromF,WattsA,GrobnerG. Two types ofAlzheimer’s
beta-amyloid (1-40) peptide membrane interactions: aggregation pre-
venting transmembrane anchoring versus accelerated surface fibril for-
mation. J Mol Biol 2004;335:1039–49.
[5] Bradford MM. A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein dye
binding. Anal Biochem 1976;72:248–54.
[6] Bucciantini M, Calloni G, Chiti F, Formigli L, Nosi D, Dobson CM,
et al. Prefibrillar amyloid protein aggregates share common features of
cytotoxicity. J Biol Chem 2004;279:31374–82.
[7] Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, et
al. Inherent toxicity of aggregates implies a common origin for protein
misfolding diseases. Nature 2002;416:507–11.
[8] BurdickD,Kosmoski J, KnauerMF,GlabeCG. Preferential adsorption,
internalization and resistance to degradation of the major isoform of
the Alzheimer’s amyloid peptide Ab 1-42, in differentiated PC12 cells.
Brain Res 1997;746:275–84.
[9] Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence of oxida-
tive damage in Alzheimer’s disease brain: central role for amyloid
beta-peptide. Trends Mol Med 2001;12:7548–54.
C. Cecchi et al. / Neurobiology of Aging 28 (2007) 863–876 875
[10] Butterfield DA, Bush AI. Alzheimer’s amyloid b-peptide (1-42):
involvement of methionine residue 35 in the oxidative stress and
neurotoxicity properties of this peptide. Neurobiol Aging 2004;25:
563–8.
[11] Butterfield DA. Proteomics: a new approach to investigate oxidative
stress in Alzheimer’s disease brain. Brain Res 2004;1000:1–7.
[12] Butterifield DA. Amyloid beta-peptide (1-42)-induced oxidative
stress and neurotoxicity: implication for neurodegeneration in
Alzheimer’s disease brain. A review. Free Radic Res 2002;36:1307–
13.
[13] Canevari L, Abramov AY, Duchen MR. Toxicity of amyloid beta pep-
tide: tales of calcium, mitochondria, and oxidative stress. Neurochem
Res 2004;29:637–50.
[14] Cecchi C, Baglioni S, Fiorillo C, Liguri G, Nosi D, Rigacci S, Buc-
ciantini M, Stefani M. Different cell lines are variously affected
by the exposure to prefibrillar amyloid aggregates. J Cell Sci
2005;118:3459–70.
[15] Cecchi C, Fiorillo C, Sorbi S, Latorraca S, Nacmias B, Bagnoli S,
et al. Oxidative stress and reduced antioxidant defenses in periph-
eral cells from familial Alzheimer’s patients. Free Radic Biol Med
2002;33:1372–9.
[16] Cecchi C, Latorraca S, Sorbi S, Iantomasi T, Favilli F, Vincenzini MT,
et al. Gluthatione level is altered in lymphoblasts from patients with
familial Alzheimer’s disease. Neurosci Lett 1999;275:152–4.
[17] Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr
2000;71:621S–9S.
[18] Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, et al.
Mutant presenilins of Alzheimer’s disease increase production of 42-
residue amyloid beta-protein in both transfected cells and transgenic
mice. Nat Med 1997;3:67–72.
[19] Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA,
Selkoe DJ, et al. Natural oligomers of the amyloid-beta protein specif-
ically disrupt cognitive function. Nat Neurosci 2005;8:79–84.
[20] Cruts M, Van Broeckoven C. Molecular genetics of Alzheimer’s dis-
ease. Ann Med 1998;30:560–5.
[21] Datki Z, Juhasz A, Galfi M, Soos K, Papp R, Zadori D, et al.
Method for measuring neurotoxicity of aggregating polypeptides with
the MTT assay on differentiated neuroblastoma cells. Brain Res Bull
2003;62:223–9.
[22] Datki Z, Papp R, Zadori D, Soos K, Fulop L, Juhasz A, et al. In
vitro model of neurotoxicity of Abeta 1-42 and neuroprotection by
a pentapeptide: irreversible events during the first hour. Neurobiol Dis
2004;17:507–15.
[23] Dobson CM. Protein folding and misfolding. Nature 2003;426:
884–90.
[24] Esterbauer H, Schaur RJ, Zollner H. Chemistry and Biochemistry of
4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic
Biol Med 1991;11:81–128.
[25] Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J,
et al. Involvement of caspases in proteolytic cleavage of Alzheimer’s
amyloid-beta precursor protein and amyloidogenic A beta peptide for-
mation. Cell 1999;97:395–406.
[26] Green JD, Kreplak L, Goldsbury C, Li Blatter X, Stolz M, Cooper GS,
et al. Atomic force microscopy reveals defects within mica supported
lipid lilayers induced by the amyloidogenic human amylin peptide. J
Mol Biol 2004;342:877–87.
[27] Guo G, Sopher BL, Pham DG, Furukawa K, Robinson N, Martin GM,
et al. Alzheimer’s presenilin mutation sensitizes neural cells to apop-
tosis induced by trophic factor withdrawal and amyloid beta-peptide:
involvement of calcium and oxyradicals. J Neurosci 1997;17:4212–
22.
[28] Harada J, Sugimoto M. Activation of caspase-3 in beta-amyloid-
induced apoptosis of cultured rat cortical neurons. Brain Res 1999;
842:311–23.
[29] Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s dis-
ease: progress and problems on the road of therapeutics. Science
2002;297:353–6.
[30] Harris ME, Hensley K, Butterfield DA, Leedle RA, Carney JM.
Direct evidence of oxidative injury produced by the Alzheimer beta-
amyloid peptide (1-40) in cultured hippocampal neurons. Exp Neurol
1995;131:193–202.
[31] Hashimoto M, Rockenstein E, Crews L, Masliah E. Role of pro-
tein aggregation in mitochondrial dysfunction and neurodegenera-
tion in Alzheimer’s and Parkinson’s diseases. Neuromol Med 2003;4:
21–36.
[32] Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, et
al. A model for beta-amyloid aggregation and neurotoxicity based on
free radical generation by the peptide: relevance to Alzheimer disease.
Proc Natl Acad Sci USA 1994;91:3270–4.
[33] Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, Zhong Y. Dis-
secting the pathological effects of human Abeta40 and Abeta42 in
Drosophila: a potential model for Alzheimer’s disease. Proc Natl Acad
Sci USA 2004;101:6623–8.
[34] Jordan J, GalindoMF,Miller RJ. Role of calpain- and interleukin-1 beta
converting enzyme-like proteases in the beta-amyloid-induced death
of rat hippocampal neurons in culture. J Neurochem 1997;68:1612–
21.
[35] Kawahara M, Kuroda Y, Arispes N, Rojas E. Alzheimer’s beta-
amyloid, human islet amylin and prion protein fragment evoke
intracellular free calcium elevations by a common mechanism in
a hypothalamic GnRH neuronal cell line. J Biol Chem 2000;275:
14077–83.
[36] Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cot-
man CW, et al. Common structure of soluble amyloid oligomers
implies common mechanism of pathogenesis. Science 2003;300:
486–9.
[37] Knauer MF, Soreghan B, Burdick D, Kosmoski J, Glabe CG.
Intracellular accumulation and resistance to degradation of the
Alzheimer amyloid A4/b protein. Proc Natl Acad Sci USA 1992;89:
7437–41.
[38] Koo EH, Lansbury PT, Kelly LW. Amyloid diseases: abnormal pro-
tein aggregation in neurodegeneration. Proc Natl Acad Sci USA
1999;96:9989–90.
[39] Koppaka V, Axelsen PH. Accelerated accumulation of amyloid beta
proteins on oxidatively damaged lipid membranes. Biochemistry
2000;39:10011–6.
[40] Kourie JI, Henry CL. Ion channel formation and membrane-
linked pathologies of misfolded hydrophobic proteins: the role of
dangerous unchaperoned molecules. Clin Exp Pharmacol Physiol
2002;29:741–53.
[41] Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP. Evi-
dence that 4-hydroxynonenal mediates oxidative stress-induced neu-
ronal apoptosis. J Neurosci 1997;17:5089–100.
[42] Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos
M, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are
potent central nervous system neurotoxins. Proc Natl Acad Sci USA
1998;95:6448–53.
[43] Lashuel HA, Hartley D, Petre BM, Walz T, Lanbury PT. Neurode-
generative disease: amyloid pores from pathogenic mutations. Nature
2002;418:291.
[44] Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ,
Cotman CW. Apoptosis is induced by b-amyloid in cultured cen-
tral nervous system neurons. Proc Natl Acad Sci USA 1993;90:
7951–5.
[45] Lovell MA, Ehmann WD, Butler SM, Markesbery WR. Ele-
vated thiobarbituric acid-reactive substances and antioxidant enzyme
activity in the brain in Alzheimer’s disease. Neurology 1995;45:
1594–601.
[46] Marcus DL, Thomas C, Rodriguez CL, Simberkoff K, Tsai JS,
Strafaci JA, et al. Increased peroxidation and reduced antioxi-
dant enzyme activity in Alzheimer’s disease. Exp Neurol 1998;150:
40–4.
[47] Markesbery WR, Carney JM. Oxidative alterations in Alzheimer’s dis-
ease. Brain Pathol 1999;9:133–46.
876 C. Cecchi et al. / Neurobiology of Aging 28 (2007) 863–876
[48] Markesbery WR, Lovell MA. 4-Hydroxynonenal, a product of lipid
peroxidation, is increased in the brain inAlzheimer’s disease.Neurobiol
Aging 1998;19:33–6.
[49] Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL,
Beyreuther K. Amyloid plaque core protein in Alzheimer disease and
Down syndrome. Proc Natl Acad Sci USA 1985;82:4245–9.
[50] Mattson MP. Oxidative stress, perturbed calcium homeostasis,
and immune dysfunction in Alzheimer’s disease. J Neurovirol
2002;8:539–50.
[51] Mattson MP. Emerging neuroprotective strategies for Alzheimer’s dis-
ease: dietary restriction, telomerase activation, and stem cell therapy.
Exp Gerontol 2000;35:489–502.
[52] MattsonMP, Guo Q, Furukawa K, PedersenWA. Presenilins, the endo-
plasmic reticulum, and neuronal apoptosis in Alzheimer’s disease. J
Neurochem 1998;70:1–14.
[53] McCormack JG, Halestrap AP, Denton RM. Role of calcium ions in
regulation of mammalian intramitochondrial metabolism. Physiol Rev
1990;70:391–425.
[54] Mecocci P,MacGarveyU,BealMF.Oxidative damage tomitochondrial
DNA is increased inAlzheimer’s disease. AnnNeurol 1994;36:747–51.
[55] Montine TJ, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts
LJ, et al. Lipid peroxidation in aging brain and Alzheimer’s disease.
Free Radic Biol Med 2002;33:620–6.
[56] Morelli L, Prat MI, Castano EM. Differential accumulation of soluble
amyloid beta peptides 1-40 and 1-42 in human monocytic and neu-
roblastoma cell lines. Implications for cerebral amyloidogenesis. Cell
Tissue Res 1999;298:225–32.
[57] Orrenius S, Zhovotovsky B, Nicotera P. Regulation of cell death: the
calcium-apoptosis link. Nat Rev 2003;4:552–65.
[58] Price DL, Tanzi RE, Borchelt DR, Sisodia SS. Alzheimer’s dis-
ease: genetic studies and transgenic models. Annu Rev Genet
1998;32:461–93.
[59] Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith
MA. 4-Hydroxynonenal-derived advanced lipid peroxidation end prod-
ucts are increased in Alzheimer’s disease. J Neurochem 1997;68:
2092–7.
[60] Smith MA, Rudnicka-Nawrot M, Richey PL, Praprotnik D, Mulvihill
P, Miller CA, et al. Carbonyl-related post-translational modification of
neurofilament protein in the neurofibrillary pathology of Alzheimer’s
disease. J Neurochem 1995;64:2660–6.
[61] Stefani M, Dobson CM. Protein aggregation and aggregate toxicity:
new insights into protein folding, misfolding diseases and biological
evolution. J Mol Med 2003;81:678–99.
[62] Subbarao KV, Richardson JS. Autopsy samples of Alzheimer’s cortex
show increased peroxidation in vitro. J Neurochem 1990;55:342–5.
[63] Takeda K, Araki W, Tabira T. Enhanced generation of intracellular
Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2. Eur
J Neurosci 2004;19:258–64.
[64] The Dementia Study Group of the Italian Neurological Society Guide-
lines for the diagnosis of dementia and Alzheimer’s disease. Ital J
Neurol Sci 2000;21:87–194.
[65] Turmaine M, Raza A, Mahal A, Mangiarini L, Bates GP, Davies
SW. Nonapoptotic neurodegeneration in a transgenic mouse model
of Huntington’s disease. Proc Natl Acad Sci USA 2000;97:
8093–7.
[66] Varadarajan S, Yatin S, Aksenova M, Butterfield DA. Review:
Alzheimer’s amyloid beta-peptide-associated free radical oxidative
stress and neurotoxicity. J Struct Biol 2000;130:184–208.
[67] Velez-Pardo C, Arroyave ST, Lopera F, Castano AD, Jimenez Del Rio
MJ. Ultrastructure evidence of necrotic neural cell death in famil-
ial Alzheimer’s disease brains bearing presenilin-1 E280A mutation.
Alzheimer’s Dis 2001;3:409–15.
[68] Volicer M. Free radicals in the development of Alzheimer’s disease.
Neurobiol Aging 1990;11:567–71.
[69] Walsh DM, Klyubin I, Fadeeva JV, CullenWK, Anwyl R,WolfeMS, et
al. Naturally secreted oligomers of amyloid beta protein potently inhibit
hippocampal long-term potentiation in vivo. Nature 2002;416:535–9.
[70] Wogulis M, Wright S, Cunningham D, Chilcote T, Powell K, Rydel
RE. Nucleation-dependent polymerization is an essential component of
amyloid-mediated neuronal cell death. J Neurosci 2005;25:1071–80.
[71] Xie J, Guo Q. AATF protects neural cells against oxidative damage
induced by amyloid b-peptide. Neurobiol Dis 2004;16:150–7.
[72] Yang AJ, Chandswangbhuvana D, Shu T, Henschen A, Glabe CG.
Intracellular accumulation of insoluble, newly synthesized Ab n-42
in amyloid precursor protein-transfected cells that have been treated
with Ab 1-42*. J Biol Chem 1999;274:20650–6.
[73] Yao ZX, Drieu K, Szweda LI, Papadopoulos V. Free radicals and lipid
peroxidation do not mediate beta-amyloid-induced neuronal cell death.
Brain Res 1999;847:203–10.
